This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
ANGLE
Strategic Marketing & Creative Services
Collaborating with the Senior Management Team to commercialise and reposition ANGLE, transitioning focus from research institutes, to targeting key decision-makers in global pharmaceutical organisations within the multi-billion dollar liquid biopsy market.
ANGLE is a global leader in Circulating Tumour Cells (CTCs) capture, offering innovative ‘sample to answer’ solutions that rival the more traditional laboratory-service based approach, enabling incredible efficiencies for pharmaceutical organisations. In early 2022, ANGLE’s Parsortix® PC1 system was the first technology to receive FDA clearance for the capture of CTCs from metastatic breast cancer patients blood.
Having first engaged TMC in early 2021, our team has worked alongside key decision makers, to offer strategic support in the commercialisation of their products and services. Initially, the key requirements of such support focused on elevating ANGLE’s profile and visibility with pharmaceutical organisations, transitioning their business structure, developing products and service divisions based on commercial opportunities.
Key to stimulating interest and awareness of their brand, was establishing Parsortix® as a technology that drives all products and services. Positioning ANGLE as a technology partner in precision medicine to global pharmaceutical businesses required a full-scale brand audit and strategic roadmap.
The newly established laboratory services required a pipeline of opportunities to grow sales volumes in North America, European Union and the United Kingdom.
The Results
4.4m LinkedIn Campaign impressions
20k Clicks from Google Ads campaigns
+379% increase in LinkedIn followers over 12 months
Whilst TMC was originally appointed to provide strategic counsel in the commercialisation of the Parsortix® system, the strength of the relationship has since led to a robust and comprehensive service offering, united in the goal of maintaining ANGLE’s position as a leader in liquid biopsies.
This has included, to date;
- Brand development and the creation of a new corporate identity, evidenced throughout every consumer and stakeholder touchpoint.
- 3D modelling and prototyping of Parsortix® technology.
- Dedicated and fully-responsive, marketing and client relationship support, providing content marketing plans, community management and strategic reporting.
- Paid amplification through the delivery and management of multiple Google Ads campaigns (Responsive Search and Display) and highly-targeted, lead-generation focused LinkedIn Sponsored Content & Messaging.
- Bespoke e-mail marketing suite to signal attendance at key events, alert subscribers to new scientific releases and press updates.
- Concept, design and delivery of exhibition collateral, including high impact booth graphics.
- Launch campaigns to increase audience awareness of product offerings, in support of specialist press targets and publications.
- The concept, design and wireframe of a new branded website, built around a strategic, conversion-led user funnel (due to launch in Q2 2023).
- Upcoming management and delivery of photo and video shoots, producing an emotive corporate video, positioning of key thought leaders and other digital assets.
What next?
Ready to ignite your marketing communications through strategic support?
If you are interested in an obligation-free conversation about how we can develop your brand, please contact us on: +44 (0)1260 295700 or email hello@wearetmc.com.